Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, Irvine
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient must have: metastatic, disseminated or recurrent colon or rectal cancer
Patient to receive weekly or biweekly chemotherapy for at least 4 cycles (4 weeks) Examples include: 5FU or 5FU/leucovorin given once weekly Irinotecan (single agent) given once weekly 5FU/leucovorin/irinotecan given once weekly
Patient must be able to be taught to administer GM-CSF subcutaneously
You may not be if
Known allergic or other adverse reaction to GM-CSF
Chemotherapy administration more frequently than bi-weekly
Pregnant or lactating women
Clareo Health | Cellular Immune Augmentation in Colon and Rectal Cancer
